Literature DB >> 23228393

β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.

Longmei Zhao1, Bhamini Purandare, Jian Zhang, Basil M Hantash.   

Abstract

Human leukocyte antigen-G (HLA-G) is a nonclassical HLA class-I molecule and plays a role in tissue specific immunoregulation. Many studies have addressed functional aspects of β2-microglobulin (β2m)-associated HLA-G1. β2m-free HLA-G has been found in human placental cytotrophoblasts and pancreatic β cells although its function remains unclear. In the present study, we investigated the function of β2m-free HLA-G by transfecting HLA-G1 and -G3 into human β2m deficient rat pancreatic β cell carcinoma (BRIN-BD11) cells. RT-PCR and western blots studies confirmed high expression of HLA-G1 and -G3 in -G1 and -G3 transfectants, respectively. HLA-G1 and -G3 were detected mainly in intracellular compartments of BRIN-BD11 transductants by confocal fluorescent microscopy and flow cytometry. Functional analysis revealed that β2m-free HLA-G promoted xenogeneic cytotoxic lysis of BRIN-BD11 cells by natural killer (NK) cells and increased production of IL-1β, TNF-α, and IFN-γ. Stimulation of cytotoxic lysis was impaired by blocking the MAPK and DNA-PKcs pathways in NK cells. Importantly, treatment with 33mAb, a KLR2DL4 receptor agonist, induced NK-mediated cytotoxic lysis of BRIN-BD11 cells transfected with a mock vector. Our data suggest that β2m-free HLA-G activates NK cells via engagement of KLR2DL4 receptors.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228393     DOI: 10.1016/j.humimm.2012.11.022

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach.

Authors:  Faezeh Hosseinzadeh; Jafar Ai; Abbas Hajifathali; Samad Muhammadnejad; Somayeh Ebrahimi-Barough; Iman Seyhoun; Tahereh Komeili Movahed; Sadegh Shirian; Fatemeh Hosseinzadeh; Sajjad Ahmadpour; Mohammadreza Alijani; Javad Verdi
Journal:  Pharmacol Rep       Date:  2022-01-28       Impact factor: 3.024

Review 2.  Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Xiaoyin Bu; Jinman Zhong; Weiru Li; Shengchun Cai; Ya Gao; Baohong Ping
Journal:  Ann Hematol       Date:  2021-03-11       Impact factor: 3.673

Review 3.  HLA-G as a tolerogenic molecule in transplantation and pregnancy.

Authors:  Vera Rebmann; Fabiola da Silva Nardi; Bettina Wagner; Peter A Horn
Journal:  J Immunol Res       Date:  2014-07-21       Impact factor: 4.818

4.  Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Adi Reches; Christine Stoehr; Chiara Massa; Evamaria Gonschorek; Stefan Huettelmaier; Juliane Braun; Sven Wach; Bernd Wullich; Verena Spath; Ena Wang; Francesco M Marincola; Ofer Mandelboim; Arndt Hartmann; Barbara Seliger
Journal:  Oncotarget       Date:  2016-05-03

Review 5.  Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730

Review 6.  The many faces of human leukocyte antigen-G: relevance to the fate of pregnancy.

Authors:  Mette Dahl; Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  J Immunol Res       Date:  2014-03-04       Impact factor: 4.818

Review 7.  Some basic aspects of HLA-G biology.

Authors:  Estibaliz Alegre; Roberta Rizzo; Daria Bortolotti; Sara Fernandez-Landázuri; Enrico Fainardi; Alvaro González
Journal:  J Immunol Res       Date:  2014-04-09       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.